Allergan Plc bought Topokine Therapeutics for $85 million and certain milestone payments.
Allergan is based in Dublin for tax purposes and keeps its U.S. headquarters in New Jersey. It maintains an aesthetics medicine hub in Irvine.
Topokine is privately held and based in Boston. It develops topical treatments for subcutaneous fat.
One of its products is an ointment in Phase 3 development for treatment of bags under the eyes, and another is a gel in Phase 2 trials for the topical reduction of laugh lines.
Allergan’s $160 billion merger with Pfizer Inc. in New York City was called off earlier this month, and Allergan has said it’s seeking “growth pharma” acquisitions to complement its Irvine lines.
